BREAKING: Oxford and AstraZeneca's COVD-19 vaccine trials put on a hold after a UK participant had a 'serious' suspected reaction to the leading shot candidate
Phase 3 trials for the coronavirus vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a 'serious adverse event' was reported in a participant in the UK, according to Stat News.
Serious adverse events are suspected reactions to vaccines or drugs that require hospitalization, are life-threateningly or deadly.
It's unclear what the exact nature of the reaction was, but a person familiar with the matter told Stat News that the person is expected to recover.
Trial holds are not uncommon, but it is a blow to worldwide hopes for a shot to be ready in the coming months, as the AstraZeneca shot was considered by many - including the World Health Organization - to be the leading candidate worldwide.
Phase 3 trials for the coronavirus vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a 'serious adverse event' was reported in a participant in the UK